Surg Endosc27 Nov 2023
Analyzing 34 cases with right aortic arch (RAA) or double aortic arch (DAA) and esophageal cancer, the study found that esophagectomy, whether via thoracotomy or thoracoscopic surgery, can be safely performed for both conditions. Patients, predominantly Japanese males with squamous cell carcinoma, commonly underwent left…
J Gastrointest Surg27 Nov 2023
Video-based surgical coaching, recognized as a valuable tool for continuous professional growth, is explored further in this second part of the series. Researchers focus on its practical applications for team-based quality improvement, particularly in trauma bay settings. The paper delves into the associated risks, addressing…
J Gastrointest Surg27 Nov 2023
Analyzing 37 studies covering January 2000 to October 2021, researchers explored surgical cancer care in US safety-net hospitals (SNHs). Breast cancer (43%), colorectal (30%), and hepatopancreatobiliary (16%) cases were most represented. Barriers like financial constraints, cultural/language issues, and insurance limitations were common, contributing to advanced…
J Surg Res27 Nov 2023
Analyzing over 600,000 cases at Veterans Affairs teaching hospitals, this study delves into resident operative autonomy, revealing distinct patient and case differences. In cases where residents operate independently, patients were younger, had lower comorbidities, and underwent less complex procedures. Notably, core general surgery cases dominated,…
Ann Surg26 Nov 2023
In the clash of surgical titans for pancreatic or periampullary tumors, laparoscopic and open approaches square off. The 3-year showdown reveals no knockout punches. Among the contenders, laparoscopic pancreaticoduodenectomy (LPD) doesn't outshine open PD in the ring of overall survival (OS). Both LPD and open…
Endocrine Surgery26 Nov 2023
In the thyroid cancer arena, the study unveils the tricky identity crisis of anaplastic thyroid carcinoma (ATC). Often emerging from differentiated thyroid carcinoma (DTC), ATC's rebel nature complicates diagnosis. Researchers scoured 36 cases, discovering ATC's deceptive biomarker profile. While TTF1 stays mum, PAX8 and divergent…
JAMA Surg26 Nov 2023
A retrospective study scrutinizes the dilemma of managing acute cholecystitis during pregnancy. Cholecystectomy, performed in just 34.5% of cases, emerges as a protagonist, significantly lowering adverse pregnancy outcomes (APOs) risk throughout all trimesters. While supporting guidelines, the study suggests a potential plot twist—greater adherence to…
Ann Surg Oncol26 Nov 2023
Surgeons pioneering laparoscopic spleen-preserving distal pancreatectomy (lspdp) embraced the gastrohepatic ligament approach, deftly navigating preservation of splenic vessels. With a concise operation time of 186 minutes and minimal blood loss (37 ml), their approach, showcased in a video, emerges as a strategic option for low-grade…
Ann Surg Oncol26 Nov 2023
In the realm of pancreatoduodenectomy, a study unfolds a CT-based crystal ball. Researchers spot predictive markers—pancreatic neck thickness (>1.3 cm), intra-abdominal distance (>5.8 cm), soft pancreas, and narrow duct—signaling heightened risk of postoperative pancreatic fistula. Notably, abdominal wall thickness and obesity play no role. This…
World J Gastroenterol26 Nov 2023
Examining 2013 publications, researchers spotlight the surge in gastric cancer immunotherapy research, with China dominating contributions. Keywords like "tumor microenvironment" and "adoptive immunotherapy" emerged as hotspots. Analysis of clinical trials underscores progress, emphasizing immune checkpoint inhibitors and chimeric antigen receptor T-cells as promising options. The…